In a significant move within the healthcare sector, Spire Healthcare’s second-largest shareholder is pursuing a full acquisition of the company. This development stems from a prolonged sale process initiated due to pressure from Harwood Capital Management, a hedge fund.
Strategic Review and Sale Process
Spire Healthcare began a strategic review in September 2025. This move was in response to the interests of Harwood Capital Management. Subsequently, the company engaged in discussions with private equity firms, including Bridgepoint and Triton. However, Triton eventually withdrew from the negotiations.
Current Financial Expectations
As the company navigates this potential acquisition, it reports that its trading results through April 2026 align with expectations. Spire anticipates that its adjusted core profit for 2026 will reflect similar levels to those of 2025, suggesting a stable financial outlook amidst ongoing changes.
Market Implications
The deadline for a firm offer, set for June 11, 2026, intensifies the scrutiny of Spire’s stock. Currently, shares are trading around 215.5p, with the market estimating that a price of 250p could reflect the deal’s risk. This spread is influenced by various factors, including potential financing, the likelihood of other bidders, and investor confidence in the major shareholder’s willingness to pursue the acquisition.
Historical Context and Shareholder Sentiment
Historically, Spire’s shares have fluctuated, with a notable peak at 411p in 2016. Toscafund, which has increased its stake to nearly 11%, previously opposed a 250p proposal from Ramsay Health Care in 2021. This familiar figure resurfaces in current discussions, reflecting previous valuation metrics. Shareholders are now assessing whether past reference prices are still relevant, given the changes in the business and the growing costs in UK healthcare.
Conclusion
As Spire Healthcare’s second-largest shareholder pursues a complete acquisition, the upcoming June deadline will determine the trajectory of its stock. The unfolding events will provide crucial insight into the future of Spire in a rapidly changing healthcare market.
